BioSpace News Archive

Press Releases

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer’s Disease Assessment in Primary Care

February 11, 2026
·
3 min read
Press Releases

KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment

February 11, 2026
·
19 min read
Press Releases

Precision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular Dystrophy

February 11, 2026
·
9 min read
Press Releases

Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months

February 11, 2026
·
5 min read
Press Releases

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026

February 11, 2026
·
2 min read
Press Releases

Ionis to hold fourth quarter and full year 2025 financial results webcast

February 11, 2026
·
1 min read
Press Releases

MBX Biosciences to Participate in Upcoming Investor Conferences - February 11, 2026

February 11, 2026
·
1 min read
Press Releases

VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego

February 11, 2026
·
4 min read
Press Releases

Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit

February 11, 2026
·
6 min read
Press Releases

Denovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating Psychosis

February 11, 2026
·
3 min read